Your browser doesn't support javascript.
loading
Association of baseline neutrophil-to-eosinophil ratio with response to nivolumab plus ipilimumab in patients with metastatic renal cell carcinoma.
Tucker, Matthew D; Brown, Landon C; Chen, Yu-Wei; Kao, Chester; Hirshman, Nathan; Kinsey, Emily N; Ancell, Kristin K; Beckermann, Kathryn E; Davis, Nancy B; McAlister, Renee; Schaffer, Kerry; Armstrong, Andrew J; Harrison, Michael R; George, Daniel J; Rathmell, W Kimryn; Rini, Brian I; Zhang, Tian.
Afiliação
  • Tucker MD; Vanderbilt University Medical Center, Department of Medicine, Division of Hematology and Oncology, 777 PRB, 2220 Pierce Avenue, Nashville, TN, TN 37232, USA.
  • Brown LC; Vanderbilt-Ingram Cancer Center, VUMC, 777 PRB, 2220 Pierce Avenue, Nashville, TN, NC 27710, USA.
  • Chen YW; Duke Cancer Institute Center for Prostate and Urologic Cancers, Departments of Medicine, Surgery, and Pharmacology and Cancer Biology, Duke University, DUMC Box 103861, Durham, NC, USA.
  • Kao C; Division of Medical Oncology, Department of Medicine, Duke University, DUMC 103861, Durham, NC, NC 27710, USA.
  • Hirshman N; Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
  • Kinsey EN; Vanderbilt University Medical Center, Department of Medicine, Division of Hematology and Oncology, 777 PRB, 2220 Pierce Avenue, Nashville, TN, TN 37232, USA.
  • Ancell KK; Vanderbilt-Ingram Cancer Center, VUMC, 777 PRB, 2220 Pierce Avenue, Nashville, TN, NC 27710, USA.
  • Beckermann KE; Duke Cancer Institute Center for Prostate and Urologic Cancers, Departments of Medicine, Surgery, and Pharmacology and Cancer Biology, Duke University, DUMC Box 103861, Durham, NC, USA.
  • Davis NB; Duke Cancer Institute Center for Prostate and Urologic Cancers, Departments of Medicine, Surgery, and Pharmacology and Cancer Biology, Duke University, DUMC Box 103861, Durham, NC, USA.
  • McAlister R; Duke Cancer Institute Center for Prostate and Urologic Cancers, Departments of Medicine, Surgery, and Pharmacology and Cancer Biology, Duke University, DUMC Box 103861, Durham, NC, USA.
  • Schaffer K; Division of Medical Oncology, Department of Medicine, Duke University, DUMC 103861, Durham, NC, NC 27710, USA.
  • Armstrong AJ; Vanderbilt University Medical Center, Department of Medicine, Division of Hematology and Oncology, 777 PRB, 2220 Pierce Avenue, Nashville, TN, TN 37232, USA.
  • Harrison MR; Vanderbilt-Ingram Cancer Center, VUMC, 777 PRB, 2220 Pierce Avenue, Nashville, TN, NC 27710, USA.
  • George DJ; Vanderbilt University Medical Center, Department of Medicine, Division of Hematology and Oncology, 777 PRB, 2220 Pierce Avenue, Nashville, TN, TN 37232, USA.
  • Rathmell WK; Vanderbilt-Ingram Cancer Center, VUMC, 777 PRB, 2220 Pierce Avenue, Nashville, TN, NC 27710, USA.
  • Rini BI; Vanderbilt University Medical Center, Department of Medicine, Division of Hematology and Oncology, 777 PRB, 2220 Pierce Avenue, Nashville, TN, TN 37232, USA.
  • Zhang T; Vanderbilt-Ingram Cancer Center, VUMC, 777 PRB, 2220 Pierce Avenue, Nashville, TN, NC 27710, USA.
Biomark Res ; 9(1): 80, 2021 Nov 03.
Article em En | MEDLINE | ID: mdl-34732251
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Biomark Res Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Biomark Res Ano de publicação: 2021 Tipo de documento: Article